FDA warns about “Xian Ling” pain product after hidden tapentadol and meloxicam
FDA says lab testing found the “Xian Ling” pain product contains undeclared tapentadol (opioid) and meloxicam (NSAID)—not on the label.
FDA
-
-
FDA Proposes Hub-and-Spoke Drug Registration Change; Comments Due Sept. 11
FDA proposes rule to let hub-and-spoke drug networks register as one and clarifies some foreign import listing; comments due Sept. 11, 2026.
-
Groups Sue FDA Over Enforcement Policy for Unauthorized Vapes and Pouches
Pediatricians and public health groups sued FDA on July 14, 2026 over May 8 guidance they say leaves some unauthorized ENDS and nicotine pouches on shelves.
-
FDA update (July 16): Cyclospora outbreak linked to Taco Bell shredded lettuce
FDA and CDC’s July 16 update: 1,644 people reported eating Taco Bell in five states, with 94 hospitalizations and no deaths tied to shredded iceberg lettuce.
-
FDA letter urges tighter infant formula supplier oversight after July 13
United States Food Drug and Consumer Safety – On July 13, FDA asked infant formula makers to tighten supplier oversight and move faster when safety signals appear.
-
FDA Import Alert 99-52 and FSMA 801(q) import certification: what to know
United States—FDA’s Import Alert 99-52 (DWPE) ties border detention/refusal for certain foods from Indonesia to FSMA 801(q) import certification, starting Oct. 31, 2025.
-
FDA’s proposed “hub-and-spoke” drug registration rule: what it could change
FDA proposes “hub-and-spoke” networks register as one and clarifies foreign reporting; expedited updates include 5/30/120-day timelines. Comments due Sept. 11, 2026.
-
HHS ends COVID-19 EUA declarations for devices and drugs: key dates
HHS signed COVID-19 EUA declaration terminations: devices end Dec. 26, 2026, drugs/biologics June 29, 2027—tied to FDA/EUA oversight changes.
-
HHS begins phased wind-down of COVID emergency authorizations for drugs, devices
United States Public Health Safety and Legal Rules – HHS is ending COVID-era emergency use declarations on different timelines, with medical-device authority expiring first.
-
FDA proposes same tobacco registration rules for foreign makers
United States Public Health Safety and Legal Rules – FDA wants overseas tobacco makers to register and list products, closing a gap in federal oversight. ([fda.gov](https://www.fda.gov/news-events/press-announcements/fda-proposes-rule-would-help-hold-foreign-tobacco-product-manufacturers-accountable-protect-public))
-
FDA Class I chip recall puts select Zapp’s and Dirty snacks on the July Fourth check list
FDA’s highest-risk recall covers select Zapp’s and Dirty potato chips nationwide, so shoppers should check labels before the holiday weekend. ([fda.gov](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/utz-quality-foods-llc-issues-voluntary-recall-certain-limited-varieties-zapps-and-dirty-potato-chips))
-
HHS ends COVID EUA declarations for drugs and devices
United States Public Health Safety and Legal Rules – HHS is ending COVID emergency-use declarations for drugs, biologics and devices, but the phaseout is staggered.
-
Parents told to stop using Nara infant formula after botulism outbreak
FDA and CDC say families should stop using recalled Nara powdered infant formula while investigators examine three infant botulism cases.
-
United States: Nara Organics formula recall follows 3 infant botulism cases
FDA and CDC say three infants in California, Pennsylvania and Washington were hospitalized as Nara Organics recalled all lots of infant formula.
-
United States: Target recalls Up & Up baby wipes after FDA finds bacteria
Target recalled two Up & Up baby wipe lines nationwide after FDA testing found bacteria in samples, with infants and immunocompromised users most at risk.
-
United States: FDA warns on 7 million Omnipod pods in voluntary correction
FDA says specific Omnipod lots may underdeliver insulin. Users should check lot numbers, stop using affected pods, and request free replacements.
-
Nationwide infant formula recall raises evening safety concerns for parents
Parents should check a2 Platinum Premium infant formula tonight after an FDA-posted recall over possible cereulide contamination in three U.S.-sold batches.
